Literature DB >> 19196680

Targeted therapy for advanced colorectal cancer--more is not always better.

Robert J Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196680     DOI: 10.1056/NEJMe0809343

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  35 in total

1.  SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin.

Authors:  Jong-Shiaw Jin; Tang-Yi Tsao; Pei-Chang Sun; Cheng-Ping Yu; Ching Tzao
Journal:  Pathol Oncol Res       Date:  2012-01-20       Impact factor: 3.201

Review 2.  Diverse array-designed modes of combination therapies in Fangjiomics.

Authors:  Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2015-04-13       Impact factor: 6.150

3.  Cost-effectiveness analysis of capecitabine plus bevacizumab versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer from Chinese societal perspective.

Authors:  P-F Zhang; F Wen; J Zhou; J-X Huang; K-X Zhou; Q-J Wu; X-Y Wang; M-X Zhang; W-T Liao; Q Li
Journal:  Clin Transl Oncol       Date:  2019-05-06       Impact factor: 3.405

4.  Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells.

Authors:  Xiao-Yu Dai; Bao-Feng Zhou; Yang-Yang Xie; Jie Lou; Ke-Qiang Li
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

5.  Infused chemotherapy use in the elderly after patent expiration.

Authors:  Rena M Conti; Meredith B Rosenthal; Blase N Polite; Peter B Bach; Ya-Chen Tina Shih
Journal:  J Oncol Pract       Date:  2012-05       Impact factor: 3.840

6.  Prevalence of off-label use and spending in 2010 among patent-protected chemotherapies in a population-based cohort of medical oncologists.

Authors:  Rena M Conti; Arielle C Bernstein; Victoria M Villaflor; Richard L Schilsky; Meredith B Rosenthal; Peter B Bach
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

7.  Reform of the Buy-and-Bill System for Outpatient Chemotherapy Care Is Inevitable: Perspectives from an Economist, a Realpolitik, and an Oncologist.

Authors:  Blase Polite; Rena M Conti; Jeffery C Ward
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

Review 8.  Optical molecular imaging and its emerging role in colorectal cancer.

Authors:  Rahul A Sheth; Umar Mahmood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

Review 9.  The Pharmacological Costs of Complete Liver Resections in Unselected Advanced Colorectal Cancer Patients: Focus on Targeted Agents. A Review of Randomized Clinical Trials.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2016-12

10.  A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation.

Authors:  Ekaterina A Alyamkina; Valeriy P Nikolin; Nelly A Popova; Evgenia V Dolgova; Anastasia S Proskurina; Konstantin E Orishchenko; Yaroslav R Efremov; Elena R Chernykh; Alexandr A Ostanin; Sergey V Sidorov; Dmitriy M Ponomarenko; Stanislav N Zagrebelniy; Sergey S Bogachev; Mikhail A Shurdov
Journal:  Genet Vaccines Ther       Date:  2010-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.